|
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
07 October 2008
The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.
|
|
|
|
Biomedical Diagnostics Institute Purchases Biacore A100 Label-free Protein Interaction Analysis System for Development of Novel Clinical Diagnostics
06 October 2008
The Biomedical Diagnostics Institute (BDI) based at Dublin City University (DCU) announced that it has invested in Biacore™ A100 label-free protein interaction analysis system.
|
|
|
|
deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
06 October 2008
deCODE genetics announced that on September 30, 2008 it received a notice from the Nasdaq Stock Market stating that for 10 consecutive trading days the market value of deCODE’s common stock had been below $50 million, the minimum level required for continued listing on The Nasdaq Global Market as set forth in Nasdaq Marketplace Rule 4450(b)(1)(A).
|
|
|
|
NCI Launches First-Ever Study to Determine if Biomarkers Can Help Guide Treatment for Lung Cancer
06 October 2008
The study, called MARVEL, will attempt to definitively establish the future value of selecting patients for treatment based on the presence or absence of EGFR activation.
|
|
|
|
CCS Cell Culture Service and Cytocentrics Agree Cooperation in the Field of Cell Line Development
06 October 2008
The agreement is aimed at the development of electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.
|
|
|
|
ServiceXS Introduces new Line of Products and Services based on DNAFORM’s Cloning and CAGE Technology
06 October 2008
DNAFORM appoints ServiceXS as exclusive distributor for its products and services using DNAFORM’s cloning and CAGE technology in the Benelux.
|
|
|
|
Scientists Identify Gene Variant Involved in Isolated Cleft Lip
06 October 2008
About 20 percent of isolated cleft lip, one of the world's most common birth defects, may be due to a one-letter difference in the DNA sequence of a gene involved in facial development, researchers supported by the National Institutes of Health report.
|
|
|
|
QIAGEN Acquires Biosystems Business from Biotage
03 October 2008
Transaction adds fundamental assay technology for high-resolution sequence detection and quantification of genetic variations.
|
|
|
|
Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec
03 October 2008
GNS will use its REFS™ software platform to process clinical data provided by Biogen Idec to identify targets and biomarkers in inflammation.
|
|
|
|
454 Life Sciences and GenomeQuest Team Up to Provide Next-Generation Sequence Search and Analysis Services
03 October 2008
GenomeQuest will offer On-Demand Informatics Service to users of the 454 Genome Sequencer FLX System under a co-marketing agreement.
|
|
|
|
Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant
02 October 2008
Expression Analysis, the industry’s leading provider of genomic services for clinical trials and research, announces they will award a Genome Wide Association Study (GWAS) Data Analysis and Resequencing Grant.
|
|
|
|
Genecards® Create Exciting New Link Between Human Genes and Chemical Reagents from Tocris Bioscience
01 October 2008
For the first time scientists investigating human genes through GeneCards, the world leading online database of genes, can directly link to relevant and cutting edge research reagents from Tocris Bioscience.
|
|
|
|
ZyGEM Licenses Rights to DNA Purification Technology from WaikatoLink
01 October 2008
ZyGEM gains exclusive worldwide rights to WaikatoLink’s intellectual property for a product for DNA purification.
|
|
|
|
DSM Publishes DNA Genome Sequence of Penicillin Producer Penicillium Chrysogenum
01 October 2008
Royal DSM has announced the publication of a paper on a breakthrough analysis of the DNA sequence of the fungus Penicillium chrysogenum.
|
|
|
|
Horizon Discovery Sign Screening and License Agreements with Agios Pharmaceuticals
01 October 2008
The agreements cover the licensing of certain X-MAN cell lines and the screening of a number of Agios lead compounds on a wide panel of genotypes.
|
|
|
|
Public-private Research Partnership Announces £5M of Projects to Accelerate Biopharmaceutical Drug Development
01 October 2008
Bioprocessing research in the UK has received a £5M boost following today’s announcement of nine projects to be funded by awards from the Bioprocessing Research Industry Club (BRIC).
|
|
|
|
NIH Announces Funding for new Epigenomics Initiative
30 September 2008
The Institute will invest $190 million over the next five years to accelerate this emerging field of biomedical research.
|
|
|
|
New Way to Control Protein Activity could Lead to Cancer Therapies, Stanford Study Shows
30 September 2008
Scientists have found a way to quickly and reversibly fine-tune the activity of individual proteins in cells and living mammals.
|
|
|
|
Expression Pathology to Collaborate in $300,000 Alberta Breast Cancer Research
30 September 2008
EPI will employ its tissue proteomics technologies to identify protein biomarkers of metastasis.
|
|
|
|
Tissue Proteomics Technology to Identify Protein Biomarkers of Metastasis
29 September 2008
Expression Pathology will collaborate with the Alberta Cancer Board, Tom Baker Cancer Centre (Calgary, Alberta) to identify protein biomarkers of breast cancer metastasis.
|
|
|
|
Oxford Gene Technology Grants Microarray Licence to BF-BIOlabs
29 September 2008
The granted licence will enable BF-BIOlabs to sell arrays and provide services that include the design and production of custom-made microarrays.
|
|
|
|
New Pig Model of Cystic Fibrosis Lays Groundwork for Better Understanding of Human Disease
29 September 2008
Researchers can now better understand how the complications of CF develop, by studying the complex and multi-organ disease process in the pig model.
|
|
|
|
NC State University Researcher Discovers Molecules that Inhibit Important Gene Regulators
26 September 2008
A NCSU chemist has discovered a molecule that can potentially stop the production of cancer cells at the very beginning of the process of cancer development.
|
|
|
|
Helicos Announces Collaboration with Children's Oncology Group to Elucidate Genomic Signatures in Ewing's Sarcoma
26 September 2008
The scientific collaboration is aimed at demonstrating the tSMS™ technology to measure the genomic variation of normal, primary and metastatic cell states.
|
|
|
|
Gene Variant Boosts Risk of Fatty Liver Disease
26 September 2008
Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation.
|
|
|
|
Roche 454 Life Sciences and IDT Enter Worldwide Exclusive Agreement for Primer Design and Supply
25 September 2008
Under this co-promotional agreement, IDT will design, synthesize, and purify the fusion primers required for certain 454 Sequencing applications under this co-promotional agreement.
|
|
|
|
NIH'S Genes Environment and Health Initiative Adds Six Studies
25 September 2008
GEI has awarded grants estimated to be up to $5.5 million over two years for six studies aimed at finding genetic factors that influence the risks for common disorders.
|
|
|
|
MorphoSys Nominates First Pre-Development Program in Antibody Collaboration
24 September 2008
MorphoSys has exercised its first option to participate in the development of a therapeutic antibody program within its collaboration with Novartis.
|
|
|
|
e2v to Establish Next Generation Biosensor System Using AbD Serotec-generated HuCAL Antibodies
24 September 2008
AbD Serotec and e2v biosensors have launched a research program to establish e2v’s proprietary biosensor system Visucare™.
|
|
|
|
250th Peer-reviewed Publication Documents the Success of 454 Sequencing
24 September 2008
The 454 Genome sequencer system accelerates the pace of discovery in diverse fields of biology.
|
|
|
|
Sequenom Announces Licensing Agreement with Genomic Nanosystems
23 September 2008
The license provides Sequenom with the exclusive right to use digital PCR methods for noninvasive prenatal diagnostics and analysis.
|
|
|
|
Seeing the Shape of Gene Silencing
23 September 2008
Researchers have devised clever new techniques to mimic the chemical marks on tightly wound DNA-protein complexes that silence gene expression.
|
|
|
|
New Technology Paves the Way for the Future of Identifying Proteins inside Cells
23 September 2008
A new technology which enables scientists to identify proteins by making a map of the energy flow inside the protein is revealed in PNAS journal.
|
|
|
|
GWC Technolgies Signs Agreement with Distributor Cybeles Life Sciences
23 September 2008
Cybeles will now be able to offer GWC’s versatile label-free detection systems to researchers throughout Singapore, Malaysia and Thailand.
|
|
|
|
Scientists Identify Genes Capable of Regulating Stem Cell Function
22 September 2008
Animal model provides insight on pathways used for adult tissue maintenance and regeneration; system for studying relationship between stem cells and cancer.
|
|
|
|
New Strategy in Fight against Cancer
22 September 2008
Scientists have identified a new strategy in the fight against cancer, having found a mechanism for switching off a chemical signal that is intimately linked to progression of the disease.
|
|
|
|
Myriad Genetics Announces Topline Results of Phase 1 Trial of Vivecon for HIV
22 September 2008
The trial demonstrated a favorable safety profile with Vivecon in 55 subjects enrolled across 9 cohorts.
|
|
|
|
Genetic Region Linked to a Five Times Higher Lung Cancer Risk
22 September 2008
A narrow region on chromosome 15 contains genetic variations strongly associated with familial lung cancer, says a study conducted by scientists at Washington University.
|
|
|
|
Children’s Hospital of Pittsburgh Researchers Identify Genetic Mutation that may Predict Organ Rejection
22 September 2008
Using a combination of technologies to scan the human genome, researchers have identified a genetic mutation that identifies transplant recipients who experience rejection.
|
|
|
|
The Genome Institute of Singapore Acquires Applied Biosystems Genomic Analysis Systems for Cancer Research
19 September 2008
ABI announced that GIS will add three new SOLiD™ Systems to its existing base of genomics analysis technologies.
|
|
|
|
The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors
19 September 2008
TCGA team describes the discovery of new genetic mutations and other types of DNA alterations with potential implications for the treatment of glioblastoma.
|
|
|
|
AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease
19 September 2008
The companies believe that the combination of GDNF gene with AMT’s gene therapy platform can allow the development of a long term treatment of Parkinson’s disease.
|
|
|
|
Newly Identified Gene Variations Account for Increased Burden of Kidney Disease among African-Americans
18 September 2008
Researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans.
|
|
|
|
GENEART Supports Advancements in Synthetic Biology as Partner of the iGEM Competition
18 September 2008
GENEART will be providing 210,000 base pairs for the competitors and provide a significant financial support for the competition.
|
|
|
|
First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio
18 September 2008
The first Arab human genome has been sequenced, as part of a large project to map the unique genetic variations of the Arab population.
|
|
|
|
AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences
18 September 2008
AnaSpec has announced that BD Bioscience has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12 Fluorescent Dyes.
|
|
|
|
Determining the Structure of Nuclear Receptor has Implications for a Host of Diseases
18 September 2008
VAI finding provides a basis for drug design for diseases related to heart and blood vessel development, human embryo development and female infertility.
|
|
|
|
Tecan and the Monash Antibody Technologies Facility Unveil Custom Monoclonal Antibody Production Facility
17 September 2008
The facility has the capacity to produce thousands of different monoclonal antibodies per year for use in research, diagnostics and therapeutic applications.
|
|
|
|
Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
17 September 2008
CompoZr™ Zinc Finger Nuclease platform of reagents enables permanent and heritable modification of the genome.
|
|
|
|
Sequenom Acquires License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
17 September 2008
The license expands Sequenom's IP portfolio of noninvasive prenatal diagnostic methods using fetal nucleic acids obtained from a maternal sample.
|
|
|